Chico's Fas (CHS) 10-Q 26 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Nov. 01, 2014	Nov. 19, 2014
Document And Entity Information [Abstract]	'	'
Entity Registrant Name	'CHICOS FAS INC	'
Entity Central Index Key	'0000897429	'
Current Fiscal Year End Date	'--01-31	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	1-Nov-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	152,935,126

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Nov. 01, 2014	Nov. 02, 2013	Nov. 01, 2014	Nov. 02, 2013
Net Sales:	'	'	'	'
Net sales	$665,569	$655,579	$2,018,304	$1,975,804
Net sales, percent	100.00%	100.00%	100.00%	100.00%
Cost of goods sold	301,776	291,569	920,148	868,808
Cost of goods sold, percent	45.30%	44.50%	45.60%	44.00%
Gross margin	363,793	364,010	1,098,156	1,106,996
Gross margin, percent	54.70%	55.50%	54.40%	56.00%
Selling, general and administrative expenses	321,574	308,528	945,360	899,689
Selling, general and administrative expenses, percent	48.30%	47.10%	46.80%	45.50%
Goodwill and trade name impairment charges	0	72,466	0	72,466
Goodwill and trade name impairment charges, percent	0.00%	11.00%	0.00%	3.70%
Acquisition and integration costs	0	0	0	914
Acquisition and integration costs, percent	0.00%	0.00%	0.00%	0.00%
Income (loss) from operations	42,219	-16,984	152,796	133,927
Income from operations, percent	6.40%	-2.60%	7.60%	6.80%
Interest income, net	44	105	75	404
Interest income (expense), net, percent	0.00%	0.00%	0.00%	0.00%
Income (loss) before income taxes	42,263	-16,879	152,871	134,331
Income before income taxes, percent	6.40%	-2.60%	7.60%	6.80%
Income tax provision	15,800	11,600	56,400	68,100
Income tax provision, percent	2.40%	1.70%	2.80%	3.40%
Net income (loss)	26,463	-28,479	96,471	66,231
Net income, percent	4.00%	-4.30%	4.80%	3.40%
Per share data:	'	'	'	'
Net income (loss) per common share-basic	$0.17	($0.18)	$0.63	$0.41
Net income (loss) per common and common equivalent share–diluted	$0.17	($0.18)	$0.63	$0.41
Weighted average common shares outstanding–basic	148,564	155,228	148,577	156,662
Weighted average common and common equivalent shares outstanding–diluted	149,037	155,228	149,093	157,604
Dividends declared per share	$0	$0	$0.23	$0.17
Chico's/Soma Intimates [Member]	'	'	'	'
Net Sales:	'	'	'	'
Net sales	418,230	415,819	1,290,239	1,255,214
Net sales, percent	62.90%	63.40%	63.90%	63.50%
White House | Black Market [Member]	'	'	'	'
Net Sales:	'	'	'	'
Net sales	224,552	218,200	655,639	643,688
Net sales, percent	33.70%	33.30%	32.50%	32.60%
Boston Proper [Member]	'	'	'	'
Net Sales:	'	'	'	'
Net sales	$22,787	$21,560	$72,426	$76,902
Net sales, percent	3.40%	3.30%	3.60%	3.90%

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Comprehensive Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Nov. 01, 2014	Nov. 02, 2013	Nov. 01, 2014	Nov. 02, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income (loss)	$26,463	($28,479)	$96,471	$66,231
Other comprehensive income (loss):	'	'	'	'
Unrealized gains (losses) on marketable securities, net of taxes	-29	70	-81	-81
Foreign currency translation adjustment, net of taxes	119	10	116	10
Comprehensive income (loss)	$26,553	($28,399)	$96,506	$66,160

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Nov. 01, 2014	Feb. 01, 2014	Nov. 02, 2013
In Thousands, unless otherwise specified
Current Assets:	'	'	'
Cash and cash equivalents	$67,172	$36,444	$52,524
Marketable securities, at fair value	124,042	116,002	197,235
Inventories	294,234	238,145	267,430
Prepaid expenses and other current assets	52,062	50,698	55,835
Total Current Assets	537,510	441,289	573,024
Property and Equipment, net	641,187	631,050	635,284
Other Assets:	'	'	'
Goodwill	171,427	171,427	171,427
Other intangible assets, net	114,927	118,196	119,269
Other assets, net	12,897	9,229	9,252
Total Other Assets	299,251	298,852	299,948
Total Assets	1,477,948	1,371,191	1,508,256
Current Liabilities:	'	'	'
Accounts payable	162,641	131,254	152,698
Other current and deferred liabilities	145,972	142,073	121,796
Total Current Liabilities	308,613	273,327	274,494
Noncurrent Liabilities:	'	'	'
Deferred liabilities	146,715	138,874	143,991
Deferred taxes	42,306	49,887	53,338
Total Noncurrent Liabilities	189,021	188,761	197,329
Stockholders’ Equity:	'	'	'
Preferred stock	0	0	0
Common stock	1,529	1,522	1,588
Additional paid-in capital	401,110	382,088	372,325
Retained earnings	577,528	525,381	662,375
Accumulated other comprehensive income	147	112	145
Total Stockholders’ Equity	980,314	909,103	1,036,433
Total liabilities and stockholders' equity	$1,477,948	$1,371,191	$1,508,256

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Nov. 01, 2014	Nov. 02, 2013
Cash Flows From Operating Activities:	'	'
Net income (loss)	$96,471	$66,231
Adjustments to reconcile net income to net cash provided by operating activities —	'	'
Goodwill and trade name impairment charges	0	72,466
Depreciation and amortization	90,514	88,123
Deferred tax (benefit) expense	-9,204	6,024
Stock-based compensation expense	20,041	19,542
Excess tax benefit from stock-based compensation	-1,654	-1,281
Deferred rent and lease credits	-13,754	-13,299
Loss on disposal and impairment of property and equipment	757	1,432
Changes in assets and liabilities:	'	'
Inventories	-56,089	-60,581
Prepaid expenses and other assets	-5,032	-1,775
Accounts payable	31,387	23,311
Accrued and other liabilities	27,655	-25,087
Net cash provided by operating activities	181,092	175,106
Cash Flows From Investing Activities:	'	'
Purchases of marketable securities	-81,134	-90,669
Proceeds from sale of marketable securities	73,062	165,852
Purchases of property and equipment, net	-98,084	-113,376
Net cash used in investing activities	-106,156	-38,193
Cash Flows From Financing Activities:	'	'
Proceeds from issuance of common stock	5,930	10,176
Excess tax benefit from stock-based compensation	1,654	1,281
Dividends paid	-34,329	-26,536
Repurchase of common stock	-17,579	-126,179
Net cash used in financing activities	-44,324	-141,258
Effects of exchange rate changes on cash and cash equivalents	116	10
Net increase (decrease) in cash and cash equivalents	30,728	-4,335
Cash and Cash Equivalents, Beginning of period	36,444	56,859
Cash and Cash Equivalents, End of period	67,172	52,524
Supplemental Disclosures of Cash Flow Information:	'	'
Cash paid for interest	230	269
Cash paid for income taxes, net	$48,321	$62,162

Basis_Of_Presentation

Basis Of Presentation	9 Months Ended
	Nov. 01, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements of Chico’s FAS, Inc. and its wholly-owned subsidiaries (collectively, the “Company”) have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by accounting principles generally accepted in the U.S. (“U.S. GAAP”) for complete financial statements. In the opinion of management, such interim financial statements reflect all normal, recurring adjustments considered necessary to present fairly the condensed consolidated financial position, the results of operations and cash flows for the interim periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. For further information, refer to the consolidated financial statements and notes thereto for the fiscal year ended February 1, 2014, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 14, 2014.
	As used in this report, all references to “we,” “us,” “our,” and “the Company,” refer to Chico’s FAS, Inc. and all of its wholly-owned subsidiaries.
	Our fiscal years end on the Saturday closest to January 31 and are designated by the calendar year in which the fiscal year commences. Operating results for the thirteen weeks and thirty-nine weeks ended November 1, 2014 are not necessarily indicative of the results that may be expected for the entire year.

New_Accounting_Pronouncements

New Accounting Pronouncements	9 Months Ended
	Nov. 01, 2014
Accounting Changes and Error Corrections [Abstract]	'
New Accounting Pronouncements	'
	New Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-09, Revenue from Contracts with Customers. The update outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. ASU 2014-09 requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for interim and annual reporting periods beginning after December 15, 2016. The standard allows for either a full retrospective or a modified retrospective transition method. We are currently assessing the potential impact of adopting this ASU, but do not, at this time, anticipate a material impact to our consolidated results of operations, financial position or cash flows.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Nov. 01, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation	'
	Stock-Based Compensation
	For the thirty-nine weeks ended November 1, 2014 and November 2, 2013, stock-based compensation expense was $20.0 million and $19.5 million, respectively. As of November 1, 2014, approximately 7.4 million shares remain available for future grants of equity awards under our 2012 Omnibus Stock and Incentive Plan.
	Restricted Stock Awards
	Restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Grant Date
				Fair Value
	Unvested, beginning of period	3,883,134		$	15.13
	Granted	1,625,050		16.47
	Vested	(1,195,585	)	15.05
	Forfeited	(311,665	)	16.23
	Unvested, end of period	4,000,934		15.61
	Performance-based restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Grant Date
				Fair Value
	Unvested, beginning of period	17,222		$	13.69
	Granted	—		—
	Vested	(17,222	)	13.69
	Forfeited	—		—
	Unvested, end of period	—		—
	Performance-based Restricted Stock Units
	For the thirty-nine weeks ended November 1, 2014, we granted performance-based restricted stock units (“PSUs”), contingent upon the achievement of a Company-specific performance goal during fiscal 2014. Any units earned as a result of the achievement of this goal will vest over 3 years from the date of grant and will be settled in shares of our common stock.
	Performance-based restricted stock unit activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Grant Date
				Fair Value
	Unvested, beginning of period	485,935		$	15.01
	Granted	657,000		16.51
	Vested	(240,596	)	15.01
	Forfeited	(55,352	)	15.72
	Unvested, end of period	846,987		16.13
	Stock Option Awards
	For the thirty-nine weeks ended November 1, 2014 and November 2, 2013, we did not grant any stock options. In the years that we granted options, we used the Black-Scholes option-pricing model to value our stock options.
	Stock option activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Exercise Price
	Outstanding, beginning of period	2,642,269		$	15.63
	Granted	—		—
	Exercised	(288,661	)	11.98
	Forfeited or expired	(272,146	)	19.78
	Outstanding, end of period	2,081,462		15.59
	Exercisable at November 1, 2014	2,051,300		$	15.67

Impairment_Charges

Impairment Charges	9 Months Ended
	Nov. 01, 2014
Asset Impairment Charges [Abstract]	'
Impairment Charges	'
	Impairment Charges
	On September 19, 2011, we acquired all of the outstanding equity of Boston Proper, Inc. (“Boston Proper”), a privately held online and catalog retailer of distinctive women’s apparel and accessories. Total cash consideration was approximately $214 million. We allocated the purchase price to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date, with the remaining unallocated purchase price recorded as goodwill.
	In the third quarter of 2013, due to sales declines in the Boston Proper catalog business due to the increasingly competitive direct-to-consumer environment and the impact of integration efforts and new initiatives, we determined that certain Boston Proper intangibles were impaired and recorded a goodwill impairment charge of $67.3 million, reducing the carrying value of Boston Proper goodwill to $74.6 million and an impairment charge related to the Boston Proper trade name of $5.2 million pre-tax, reducing the carrying value of the Boston Proper trade name to $46.0 million.

Earnings_Per_Share

Earnings Per Share	9 Months Ended
	Nov. 01, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	Earnings Per Share
	In accordance with relevant accounting guidance, unvested share-based payment awards that include non-forfeitable rights to dividends, whether paid or unpaid, are considered participating securities. As a result, such awards are required to be included in the calculation of earnings per common share pursuant to the “two-class” method. For us, participating securities are composed entirely of unvested restricted stock awards and PSUs that have met their relevant performance criteria.
	Earnings per share (“EPS”) is determined using the two-class method, as it is more dilutive than the treasury stock method. Basic EPS excludes dilution and is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period, including participating securities. Diluted EPS reflects the dilutive effect of potential common shares from non-participating securities such as stock options and PSUs.
	The following table sets forth the computation of basic and diluted EPS shown on the face of the accompanying condensed consolidated statements of income (loss) (in thousands, except per share amounts):
		Thirty-Nine Weeks Ended						Thirteen Weeks Ended
		November 1, 2014			November 2, 2013			November 1, 2014			November 2, 2013
	Numerator
	Net income (loss)	$	96,471		$	66,231		$	26,463		$	(28,479	)
	Net income and dividends declared allocated to participating securities	(2,648		)	(1,785		)	(745		)	—
	Net income (loss) available to common shareholders	$	93,823		$	64,446		$	25,718		$	(28,479	)
	Denominator
	Weighted average common shares outstanding – basic	148,577			156,662			148,564			155,228
	Dilutive effect of non-participating securities	516			942			473			—
	Weighted average common and common equivalent shares outstanding – diluted	149,093			157,604			149,037			155,228
	Net income (loss) per common share:
	Basic	$	0.63		$	0.41		$	0.17		$	(0.18	)
	Diluted	$	0.63		$	0.41		$	0.17		$	(0.18	)
	For the thirty-nine weeks ended November 1, 2014 and November 2, 2013, 0.6 million and 1.0 million potential shares of common stock, respectively, were excluded from the diluted per share calculation relating to non-participating securities, because the effect of including these potential shares was antidilutive.
	For the thirteen weeks ended November 1, 2014 and November 2, 2013, 0.5 million and 0.8 million potential shares of common stock, respectively, were excluded from the diluted per share calculation relating to non-participating securities, because the effect of including these potential shares was antidilutive.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Nov. 01, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	Fair Value Measurements
	Our financial instruments consist of cash, money market accounts, marketable securities, assets held in our non-qualified deferred compensation plan and accounts receivable and payable. Cash, accounts receivable and accounts payable are carried at cost, which approximates their fair value due to the short-term nature of the instruments.
	Marketable securities are classified as available-for-sale and as of November 1, 2014 generally consist of corporate bonds, commercial paper, municipal bonds, and U.S. government and agency securities with $92.6 million of securities with maturity dates within one year or less and $31.4 million with maturity dates over one year and less than two years.
	We consider all marketable securities available-for-sale, including those with maturity dates beyond 12 months, and therefore classify these securities within current assets on the condensed consolidated balance sheets as they are available to support current operational liquidity needs. Marketable securities are carried at fair value, with the unrealized holding gains and losses, net of income taxes, reflected in accumulated other comprehensive income until realized. For the purposes of computing realized and unrealized gains and losses, cost is determined on a specific identification basis.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. Entities are required to use a three-level hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels are defined as follows:
		Level 1	—	Unadjusted quoted prices in active markets for identical assets or liabilities
		Level 2	—	Unadjusted quoted prices in active markets for similar assets or liabilities, or; Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or; Inputs other than quoted prices that are observable for the asset or liability
		Level 3	—	Unobservable inputs for the asset or liability
	We measure certain financial assets at fair value on a recurring basis, including our marketable securities, which are classified as available-for-sale securities, certain cash equivalents, specifically our money market accounts, and assets held in our non-qualified deferred compensation plan. The money market accounts are valued based on quoted market prices in active markets. Our marketable securities are generally valued based on other observable inputs for those securities (including market corroborated pricing or other models that utilize observable inputs such as interest rates and yield curves) based on information provided by independent third party pricing entities, except for U.S. government securities which are valued based on quoted market prices in active markets. The investments in our non-qualified deferred compensation plan are valued using quoted market prices and are included in other assets on our condensed consolidated balance sheets.
	From time to time, we measure certain assets at fair value on a non-recurring basis, including evaluation of long-lived assets, goodwill and other intangible assets for impairment using company-specific assumptions which would fall within Level 3 of the fair value hierarchy. During the third quarter of fiscal 2013, we recorded a $72.5 million pre-tax impairment charge related to assets measured at fair value on a non-recurring basis, comprised of $67.3 million in Boston Proper goodwill impairment and $5.2 million pre-tax in Boston Proper trade name impairment.
	To assess the fair value of Boston Proper goodwill, we utilized both an income approach and a market approach. Inputs used to calculate the fair value based on the income approach primarily included estimated future cash flows for the catalog business, discounted at a rate that approximates a rate that would be used by a market participant. Inputs used to calculate the fair value based on the market approach included identifying multiples of sales and earnings based on guidelines for publicly traded companies and recent transactions.
	To assess the fair value of the Boston Proper trade name, we utilized a relief from royalty approach. Inputs used to calculate the fair value of the trade name primarily included future sales projections for the catalog business, discounted at a rate that approximates a rate that would be used by a market participant and estimated royalty rate.
	Fair value calculations contain significant judgments and estimates, which may differ from actual results due to, among other things, economic conditions, changes to the business model or changes in operating performance.
	During the quarter ended November 1, 2014, we did not make any transfers between Level 1 and Level 2 financial assets. Furthermore, as of November 1, 2014, February 1, 2014 and November 2, 2013, we did not have any Level 3 cash equivalents or marketable securities. We conduct reviews on a quarterly basis to verify pricing, assess liquidity, and determine if significant inputs have changed that would impact the fair value hierarchy disclosure.
	In accordance with the provisions of the guidance, we categorized our financial assets, which are valued on a recurring basis, based on the priority of the inputs to the valuation technique for the instruments, as follows:
					Fair Value Measurements at Reporting Date Using
		Balance as of November 1, 2014			Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
					(Level 1)		(Level 2)		(Level 3)
		(in thousands)
	Current Assets
	Cash equivalents:
	Money market accounts	$	2,721		$	2,721	$	—	$	—
	Marketable securities:
	Municipal securities	22,103			—		22,103		—
	U.S. government securities	1,403			1,403		—		—
	U.S. government agencies	20,313			—		20,313		—
	Corporate bonds	49,225			—		49,225		—
	Commercial paper	30,998			—		30,998		—
	Non Current Assets
	Deferred compensation plan	8,085			8,085		—		—
	Total	$	134,848		$	12,209	$	122,639	$	—
		Balance as of February 1, 2014
	Current Assets
	Cash equivalents:
	Money market accounts	$	7,509		$	7,509	$	—	$	—
	Marketable securities:
	Municipal securities	51,519			—		51,519		—
	U.S. government securities	9,812			9,812		—		—
	U.S. government agencies	9,020			—		9,020		—
	Corporate bonds	45,651			—		45,651		—
	Non Current Assets
	Deferred compensation plan	6,299			6,299		—		—
	Total	$	129,810		$	23,620	$	106,190	$	—
		Balance as of November 2, 2013
	Current Assets
	Cash equivalents:
	Money market accounts	$	17,291		$	17,291	$	—	$	—
	Marketable securities:
	Municipal securities	81,963			—		81,963		—
	U.S. government securities	32,194			32,194		—		—
	U.S. government agencies	9,013			—		9,013		—
	Corporate bonds	74,065			—		74,065		—
	Non Current Assets
	Deferred compensation plan	6,246			6,246		—		—
	Total	$	220,772		$	55,731	$	165,041	$	—

Subsequent_Events

Subsequent Events	9 Months Ended
	Nov. 01, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Events
	On November 25, 2014, we announced that our Board of Directors declared a quarterly dividend of $0.075 per share on our common stock. The dividend will be payable on December 22, 2014 to shareholders of record at the close of business on December 8, 2014. Although it is our Company’s intention to continue to pay a quarterly cash dividend in the future, any decision to pay future cash dividends will be made by the Board of Directors and will depend on future earnings, financial condition and other factors.

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Nov. 01, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Summary Of Restricted Stock Activity	'
	Restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Grant Date
				Fair Value
	Unvested, beginning of period	3,883,134		$	15.13
	Granted	1,625,050		16.47
	Vested	(1,195,585	)	15.05
	Forfeited	(311,665	)	16.23
	Unvested, end of period	4,000,934		15.61
Performance-Based Restricted Stock	'
	Performance-based restricted stock award activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Grant Date
				Fair Value
	Unvested, beginning of period	17,222		$	13.69
	Granted	—		—
	Vested	(17,222	)	13.69
	Forfeited	—		—
	Unvested, end of period	—		—
Schedule Of Performance-Based Stock Units	'
	Performance-based restricted stock unit activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Grant Date
				Fair Value
	Unvested, beginning of period	485,935		$	15.01
	Granted	657,000		16.51
	Vested	(240,596	)	15.01
	Forfeited	(55,352	)	15.72
	Unvested, end of period	846,987		16.13
Summary Of Stock Option Activity	'
	Stock option activity for the thirty-nine weeks ended November 1, 2014 was as follows:
		Number of		Weighted
		Shares		Average
				Exercise Price
	Outstanding, beginning of period	2,642,269		$	15.63
	Granted	—		—
	Exercised	(288,661	)	11.98
	Forfeited or expired	(272,146	)	19.78
	Outstanding, end of period	2,081,462		15.59
	Exercisable at November 1, 2014	2,051,300		$	15.67

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	9 Months Ended
	Nov. 01, 2014
Earnings Per Share [Abstract]	'
Schedule Of Earnings Per Share	'
	The following table sets forth the computation of basic and diluted EPS shown on the face of the accompanying condensed consolidated statements of income (loss) (in thousands, except per share amounts):
		Thirty-Nine Weeks Ended						Thirteen Weeks Ended
		November 1, 2014			November 2, 2013			November 1, 2014			November 2, 2013
	Numerator
	Net income (loss)	$	96,471		$	66,231		$	26,463		$	(28,479	)
	Net income and dividends declared allocated to participating securities	(2,648		)	(1,785		)	(745		)	—
	Net income (loss) available to common shareholders	$	93,823		$	64,446		$	25,718		$	(28,479	)
	Denominator
	Weighted average common shares outstanding – basic	148,577			156,662			148,564			155,228
	Dilutive effect of non-participating securities	516			942			473			—
	Weighted average common and common equivalent shares outstanding – diluted	149,093			157,604			149,037			155,228
	Net income (loss) per common share:
	Basic	$	0.63		$	0.41		$	0.17		$	(0.18	)
	Diluted	$	0.63		$	0.41		$	0.17		$	(0.18	)

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Nov. 01, 2014
Fair Value Disclosures [Abstract]	'
Financial Assets Valued On A Recurring Basis, Based On The Priority Of The Inputs To The Valuation Technique	'
	In accordance with the provisions of the guidance, we categorized our financial assets, which are valued on a recurring basis, based on the priority of the inputs to the valuation technique for the instruments, as follows:
				Fair Value Measurements at Reporting Date Using
		Balance as of November 1, 2014		Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
				(Level 1)		(Level 2)		(Level 3)
		(in thousands)
	Current Assets
	Cash equivalents:
	Money market accounts	$	2,721	$	2,721	$	—	$	—
	Marketable securities:
	Municipal securities	22,103		—		22,103		—
	U.S. government securities	1,403		1,403		—		—
	U.S. government agencies	20,313		—		20,313		—
	Corporate bonds	49,225		—		49,225		—
	Commercial paper	30,998		—		30,998		—
	Non Current Assets
	Deferred compensation plan	8,085		8,085		—		—
	Total	$	134,848	$	12,209	$	122,639	$	—
		Balance as of February 1, 2014
	Current Assets
	Cash equivalents:
	Money market accounts	$	7,509	$	7,509	$	—	$	—
	Marketable securities:
	Municipal securities	51,519		—		51,519		—
	U.S. government securities	9,812		9,812		—		—
	U.S. government agencies	9,020		—		9,020		—
	Corporate bonds	45,651		—		45,651		—
	Non Current Assets
	Deferred compensation plan	6,299		6,299		—		—
	Total	$	129,810	$	23,620	$	106,190	$	—
		Balance as of November 2, 2013
	Current Assets
	Cash equivalents:
	Money market accounts	$	17,291	$	17,291	$	—	$	—
	Marketable securities:
	Municipal securities	81,963		—		81,963		—
	U.S. government securities	32,194		32,194		—		—
	U.S. government agencies	9,013		—		9,013		—
	Corporate bonds	74,065		—		74,065		—
	Non Current Assets
	Deferred compensation plan	6,246		6,246		—		—
	Total	$	220,772	$	55,731	$	165,041	$	—

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details) (USD $)	9 Months Ended
In Thousands, except Share data in Millions, unless otherwise specified	Nov. 01, 2014	Nov. 02, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Compensation expense related to stock-based awards	$20,041	$19,542
Shares available for future grants	7.4	'
Performance Based Restricted Stock [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Stock-based awards, vesting period	'3 years	'

StockBased_Compensation_Summar

Stock-Based Compensation (Summary Of Restricted Stock And PSU Activity) (Details) (USD $)	9 Months Ended
	Nov. 01, 2014
Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'
Unvested, beginning of period, Number of Shares	3,883,134
Granted, Number of Shares	1,625,050
Vested, Number of Shares	-1,195,585
Forfeited, Number of Shares	-311,665
Unvested, end of period, Number of Shares	4,000,934
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'
Unvested, beginning of period, Weighted Average Grant Date Fair Value	$15.13
Granted, Weighted Average Grant Date Fair Value	$16.47
Vested, Weighted Average Grant Date Fair Value	$15.05
Forfeited, Weighted Average Grant Date Fair Value	$16.23
Unvested, end of period, Weighted Average Grant Date Fair Value	$15.61
Performance Based Award Activity [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'
Unvested, beginning of period, Number of Shares	17,222
Granted, Number of Shares	0
Vested, Number of Shares	-17,222
Forfeited, Number of Shares	0
Unvested, end of period, Number of Shares	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'
Unvested, beginning of period, Weighted Average Grant Date Fair Value	$13.69
Granted, Weighted Average Grant Date Fair Value	$0
Vested, Weighted Average Grant Date Fair Value	$13.69
Forfeited, Weighted Average Grant Date Fair Value	$0
Unvested, end of period, Weighted Average Grant Date Fair Value	$0
Performance Based Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'
Unvested, beginning of period, Number of Shares	485,935
Granted, Number of Shares	657,000
Vested, Number of Shares	-240,596
Forfeited, Number of Shares	-55,352
Unvested, end of period, Number of Shares	846,987
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'
Unvested, beginning of period, Weighted Average Grant Date Fair Value	$15.01
Granted, Weighted Average Grant Date Fair Value	$16.51
Vested, Weighted Average Grant Date Fair Value	$15.01
Forfeited, Weighted Average Grant Date Fair Value	$15.72
Unvested, end of period, Weighted Average Grant Date Fair Value	$16.13

StockBased_Compensation_Summar1

Stock-Based Compensation (Summary Of Stock Option Activity) (Details) (USD $)	9 Months Ended
	Nov. 01, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'
Outstanding, beginning of period, Number of Shares	2,642,269
Granted, Number of Shares	0
Exercised, Number of Shares	-288,661
Forfeited or expired, Number of Shares	-272,146
Outstanding, end of period, Number of Shares	2,081,462
Exercisable at November 1, 2014, Number of Shares	2,051,300
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]	'
Outstanding, beginning of period, Weighted Average Exercise Price	$15.63
Granted, Weighted Average Exercise Price	$0
Exercised, Weighted Average Exercise Price	$11.98
Forfeited or expired, Weighted Average Exercise Price	$19.78
Outstanding, end of period, Weighted Average Exercise Price	$15.59
Exercisable at November 1, 2014, Weighted Average Exercise Price	$15.67

Impairment_Charges_Details

Impairment Charges (Details) (USD $)	0 Months Ended				3 Months Ended
	Sep. 19, 2011	Nov. 01, 2014	Feb. 01, 2014	Nov. 02, 2013	Nov. 02, 2013	Nov. 02, 2013
					Boston Proper [Member]	Boston Proper Trade Name [Member]
Goodwill and Intangible Asset Impairment [Line Items]	'	'	'	'	'	'
Payments to acquire businesses, gross	$214,000,000	'	'	'	'	'
Goodwill, impairment loss	'	'	'	'	67,300,000	'
Goodwill	'	171,427,000	171,427,000	171,427,000	74,600,000	'
Impairment of intangible assets, indefinite-lived (excluding goodwill)	'	'	'	'	'	5,200,000
Indefinite-lived intangible assets (excluding goodwill)	'	'	'	'	'	$46,000,000

Earnings_Per_Share_Narrative_D

Earnings Per Share (Narrative) (Details)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Nov. 01, 2014	Nov. 02, 2013	Nov. 01, 2014	Nov. 02, 2013
Earnings Per Share [Abstract]	'	'	'	'
Antidilutive securities, number of shares	0.5	0.8	0.6	1

Earnings_Per_Share_Schedule_Of

Earnings Per Share (Schedule Of Earnings Per Share) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Nov. 01, 2014	Nov. 02, 2013	Nov. 01, 2014	Nov. 02, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net income (loss)	$26,463	($28,479)	$96,471	$66,231
Net income and dividends declared allocated to participating securities	-745	0	-2,648	-1,785
Net income (loss) available to common shareholders	$25,718	($28,479)	$93,823	$64,446
Weighted average common shares outstanding–basic	148,564	155,228	148,577	156,662
Dilutive effect of non-participating securities	473	0	516	942
Weighted average common and common equivalent shares outstanding – diluted	149,037	155,228	149,093	157,604
Net income per common share: Basic (in dollars per share)	$0.17	($0.18)	$0.63	$0.41
Net income per common share: Diluted (in dollars per share)	$0.17	($0.18)	$0.63	$0.41

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended
	Nov. 01, 2014	Nov. 02, 2013	Nov. 01, 2014	Nov. 02, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'
Securities with maturity dates less than one year	$92,600,000	'	$92,600,000	'
Securities with maturity dates over one year and less than two years	31,400,000	'	31,400,000	'
Pre-tax impairment charge	0	72,466,000	0	72,466,000
Boston Proper [Member]	'	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'
Goodwill, impairment loss	'	67,300,000	'	'
Boston Proper Trade Name [Member]	'	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'
Impairment of intangible assets, indefinite-lived (excluding goodwill)	'	$5,200,000	'	'

Fair_Value_Measurements_Financ

Fair Value Measurements (Financial Assets Valued On A Recurring Or Non-Recurring Basis, Based On The Priority Of The Inputs To The Valuation Technique) (Details) (USD $)	Nov. 01, 2014	Feb. 01, 2014	Nov. 02, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Deferred compensation plan	$8,085	$6,299	$6,246
Total	134,848	129,810	220,772
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Deferred compensation plan	8,085	6,299	6,246
Total	12,209	23,620	55,731
Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Deferred compensation plan	0	0	0
Total	122,639	106,190	165,041
Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Deferred compensation plan	0	0	0
Total	0	0	0
Municipal Securities [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	22,103	51,519	81,963
Municipal Securities [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
Municipal Securities [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	22,103	51,519	81,963
Municipal Securities [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
U.S. Government Securities [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	1,403	9,812	32,194
U.S. Government Securities [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	1,403	9,812	32,194
U.S. Government Securities [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
U.S. Government Securities [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
U.S. Government Agencies [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	20,313	9,020	9,013
U.S. Government Agencies [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
U.S. Government Agencies [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	20,313	9,020	9,013
U.S. Government Agencies [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
Corporate Bonds [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	49,225	45,651	74,065
Corporate Bonds [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
Corporate Bonds [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	49,225	45,651	74,065
Corporate Bonds [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	0	0
Commercial Paper [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	30,998	'	'
Commercial Paper [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	'	'
Commercial Paper [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	30,998	'	'
Commercial Paper [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Marketable securities	0	'	'
Money Market Accounts [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Cash equivalents	2,721	7,509	17,291
Money Market Accounts [Member] | Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Cash equivalents	2,721	7,509	17,291
Money Market Accounts [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Cash equivalents	0	0	0
Money Market Accounts [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Cash equivalents	$0	$0	$0

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended		9 Months Ended		0 Months Ended
	Nov. 01, 2014	Nov. 02, 2013	Nov. 01, 2014	Nov. 02, 2013	Nov. 25, 2014
					Subsequent Event [Member]
Subsequent Event [Line Items]	'	'	'	'	'
Dividends declared per share	$0	$0	$0.23	$0.17	$0.08